Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × aldesleukin × 90 days × Clear all

Sponsor

Conditions

Melanoma 7 Neoplasm Metastasis 5 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid 2 Leukemia 2 Colorectal Neoplasms 2 Carcinoma, Merkel Cell 2 Vulvar Diseases 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Penile Neoplasms 1 Papillomavirus Infections 1

Interventions

Magnetic Resonance Spectroscopy 5 Biopsy 4 X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 Radiotherapy 2 Nivolumab 2 Lomustine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 regorafenib 1 perillyl alcohol 1 pemigatinib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡